Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

NIH Quantum Sensing Technology Challenge

National Institutes of Health

Multi-disciplinary teams are invited to submit new biomedical use cases of existing quantum-enabled technologies and to adapt and optimize them for use in biomedical research and clinical settings.

To address the limitations in technological development and adoption of quantum-enabled sensing technologies to solve translational biomedical problems, the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), is announcing the NIH Quantum Sensing Technology Challenge, one of two parallel Prize Challenges for the NIH Quantum Biomedical Innovations and Technologies (Qu-BIT) Program , by inviting multi-disciplinary collaborative teams to propose and develop new biomedical use cases of existing quantum-enabled technologies and to adapt and optimize them for use in biomedical research and clinical settings. The three areas of interest for the NIH Quantum Sensing Technology challenge are the following:
1) Quantum-enabled Approaches to Advance Biomedical Applications,
2) Quantum-enabled Approaches for Early Detection and Diagnostics,
3) Quantum-enabled Sensing and Imaging Devices for Diagnostics and Monitoring.
The Challenge will have two stages: Ideation and Planning followed by Demonstration of Progress and Prototype Readiness.

Phase 1 Deadline: April 4, 2025

Specialties

Technology Development

Eligibility Requirements

To be eligible to submit an entry to this prize competition, interested participants (whether an Individual, Team, or Entity) must submit complete registration information via email to NIHQuantumChallenges@mail.nih.gov prior to the Submission Deadline. Additional instructions on about who must submit registration information and what must be included is provided below.

Individual participants must complete the registration. For teams, the Team Lead must complete the registration. For entities, the designated entity Point of Contact (POC) must complete the registration.

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type:

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity